Literature DB >> 8162590

Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.

G Powis1, R Bonjouklian, M M Berggren, A Gallegos, R Abraham, C Ashendel, L Zalkow, W F Matter, J Dodge, G Grindey.   

Abstract

Phosphatidylinositol-3-kinase is an important enzyme for intracellular signaling. The microbial product wortmannin and some of its analogues have been shown to be potent inhibitors of phosphatidylinositol-3-kinase. The 50% inhibitory concentration for inhibition by wortmannin is 2 to 4 nM. Kinetic analysis demonstrates that wortmannin is a noncompetitive, irreversible inhibitor of phosphatidylinositol-3-kinase, with inactivation being both time- and concentration-dependent. Wortmannin has previously been reported to be an inhibitor of myosin light chain kinase but with an inhibitory concentration of 0.2 microM. Wortmannin was found not to be an inhibitor of phosphatidylinositol-4-kinase, protein kinase C, or protein tyrosine kinase. Wortmannin inhibited the formation of phosphatidylinositol-3-phosphates in intact cells. The results of the study suggest that wortmannin and its analogues may have utility as pharmacological probes for studying the actions of phosphatidylinositol-3-kinase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8162590

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  170 in total

1.  Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells.

Authors:  A Danilkovitch; S Donley; A Skeel; E J Leonard
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.

Authors:  R Swart; I K Ruf; J Sample; R Longnecker
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  The influence of DNA double-strand break structure on end-joining in human cells.

Authors:  J Smith; C Baldeyron; I De Oliveira; M Sala-Trepat; D Papadopoulo
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

4.  Phosphatidylinositol 3-kinase is required for the expression but not for the induction or the maintenance of long-term potentiation in the hippocampal CA1 region.

Authors:  Pietro Paolo Sanna; Maurizio Cammalleri; Fulvia Berton; Cindy Simpson; Robert Lutjens; Floyd E Bloom; Walter Francesconi
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

5.  G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide.

Authors:  M J P M T Meens; N J A Mattheij; P B van Loenen; L J A Spijkers; P Lemkens; J Nelissen; M G Compeer; A E Alewijnse; J G R De Mey
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Wortmannin blocks goldfish retinal phosphatidylinositol 3-kinase and neurite outgrowth.

Authors:  Y Lavie; J Dybowski; B W Agranoff
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

7.  Pharmacological profile of phosphatidylinositol 3-kinases and related phosphatidylinositols mediating endothelin(A) receptor-operated native TRPC channels in rabbit coronary artery myocytes.

Authors:  J Shi; M Ju; W A Large; A P Albert
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

8.  Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.

Authors:  George D Dalton; Allyn C Howlett
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

9.  alpha1B-Adrenergic receptor phosphorylation and desensitization induced by transforming growth factor-beta.

Authors:  M Teresa Romero-Avila; C Fabián Flores-Jasso; J Adolfo García-Sáinz
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

10.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.